A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize delta and omicron variants of concern
Numerous vaccines have been generated to decrease the morbidity and mortality of COVID-
19. CoronaVac® is an inactivated SARS-CoV-2 vaccine approved by the World Health …
19. CoronaVac® is an inactivated SARS-CoV-2 vaccine approved by the World Health …
[HTML][HTML] Broad immunogenicity to prior SARS-CoV-2 strains and JN. 1 variant elicited by XBB. 1.5 vaccination in nursing home residents
Background SARS-CoV-2 vaccination has reduced hospitalization and mortality for nursing
home residents (NHRs). However, emerging variants coupled with waning immunity …
home residents (NHRs). However, emerging variants coupled with waning immunity …
[HTML][HTML] Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February …
M Vicentini, F Venturelli, P Mancuso… - …, 2023 - eurosurveillance.org
Background Understanding the epidemiology of reinfections is crucial for SARS-CoV-2
control over a long period. Aim To evaluate the risk of SARS-CoV-2 reinfection by …
control over a long period. Aim To evaluate the risk of SARS-CoV-2 reinfection by …
Long‐term effects of SARS‐CoV‐2 vaccination in the nursing home setting
G Rivasi, M Bulgaresi, C Bandinelli… - Journal of the …, 2022 - Wiley Online Library
Background SARS‐CoV‐2 vaccination has significantly reduced infection, hospitalization,
and lethality rates among nursing home (NH) residents, but durability of vaccine effects …
and lethality rates among nursing home (NH) residents, but durability of vaccine effects …
[HTML][HTML] Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumn …
Background Understanding the relative vaccine effectiveness (rVE) of new COVID-19
vaccine formulations against SARS-CoV-2 infection is a public health priority. A precise …
vaccine formulations against SARS-CoV-2 infection is a public health priority. A precise …
Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
The initial two-dose vaccine series and subsequent booster vaccine doses have been
effective in modulating SARS-CoV-2 disease severity and death but do not completely …
effective in modulating SARS-CoV-2 disease severity and death but do not completely …
Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK
As of June, 2021, the UK population is only partly vaccinated against COVID-19, with many
people having received just one vaccination dose (either BNT162b2 [Pfizer–BioNTech]) or …
people having received just one vaccination dose (either BNT162b2 [Pfizer–BioNTech]) or …
Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY
OpenSAFELY Collaborative, B MacKenna, HJ Curtis… - MedRxiv, 2021 - medrxiv.org
Abstract Background On December 8th 2020, NHS England administered the first COVID-19
vaccination as part of an ambitious vaccination programme during a global health …
vaccination as part of an ambitious vaccination programme during a global health …
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection
F Zhou, J Vahokoski… - npj Vaccines, 2024 - nature.com
The endemic human coronaviruses (HCoVs) circulate worldwide yet remain understudied
and unmitigated. The observation of elevated levels of HCoV reactive antibodies in COVID …
and unmitigated. The observation of elevated levels of HCoV reactive antibodies in COVID …
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel …
Background Identifying COVID-19 correlates of protection and immunity thresholds is
important for policy makers and vaccine development. We aimed to identify correlates of …
important for policy makers and vaccine development. We aimed to identify correlates of …